NeuAcalpha2-3Galbeta(38711-45-4)
- Name: NeuAcalpha2-3Galbeta
- Synonyms:alphaNeuAc2-3betaGal;NeuAcalpha2-3Galbeta;Neu5Acalpha2-3Galbeta;alpha-Neu5Ac-(2->3)-beta-D-Gal;alpha-Neup5Ac-(2->3)-beta-D-Galp;CHEBI:63155;alpha-D-N-acetylneuraminyl-(2->3)-beta-D-galactose;5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulonosyl-(2->3)-beta-D-galactose;3-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-beta-D-galactopyranose;3-O-(N-Acetyl-alpha-neuraminosyl)-beta-D-galactopyranose;5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranose;1uxa;1uxb;38711-45-4;Neu5Aca2-3Galb;alphaNeu5Ac(2-3)betaGal;Epitope ID:156993;alphaNeu5Ac(2->3)betaGal;4k66;GKHDMBQTTHCDCR-AQQDFGJOSA-N;DTXSID801232622;Q27132428
- Molecular Formula:C17H29NO14
- Molecular Weight:471.4
- CAS Registry Number:38711-45-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.38711-45-4 3-Sialyl-D-galactose (伪/尾 mixture)
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1268481-32-8/6-(1,1-Dimethylallyl)-2-(1-hydroxy-1-methylethyl)-2,3-dihydro-7H-furo[3,2-G]chromen-7-one
- 1027155-81-2/N1-(1-Dimethylcarbamoyl-2-phenyl-ethyl)-2-oxo-N4-(2-pyridin-2-YL-ethyl)-succinamide
- 771499-44-6/4-[5-(trans-4-Aminocyclohexylamino)-3-isopropylpyrazolo[1,5-A]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide
- 611207-02-4/5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione
- 105098-41-7/3',5'-Dibromo-2',4,4',6'-Tetrahydroxy Aurone
- 52715-17-0/3-[[(5-Nitro-2-furanyl)methylene]amino]-2(3H)-oxazolone
- 70170-62-6/S. typhimurium O-PS octasaccharide
- 130404-92-1/S. enteritidis O-PS octasaccharide
- 75281-88-8/4-O-alpha-D-galactopyranosyl-beta-D-galactopyranose
- 246018-80-4/Lobeline, (+)-
- 949023-23-8/(R)-lipoyl-AMP
- 856680-67-6/N-(Carboxycarbonyl)-D-phenylalanine
- 157825-89-3/Nitromethyldethia coenzyme A
- 853124-28-4/Calcium hydroxide, monohydrate
- 55069-02-8/Cpad
- 1177673-26-5/(1R)-2-{[{[(2S)-2,3-Dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(palmitoyloxy)methyl]ethyl (11E)-octadec-11-enoate
- 158982-84-4/Histidine-methyl-ester
- 1287651-14-2/5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione
- 163660-59-1/1-{3-Methyl-2-[4-(morpholine-4-carbonyl)-benzoylamino]-butyryl}-pyrrolidine-2-carboxylic acid (3,3,4,4,4-pentafluoro-1-isopropyl-2-oxo-butyl)-amide
- 38711-45-4/NeuAcalpha2-3Galbeta
- 138290-74-1/NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)b-Glc
- 130136-27-5/O-6-Deoxy-alpha-L-galactopyranosyl-(1-->2)-O-beta-D-galactopyranosyl-(1-->2)-alpha-D-xylopyranose
- 219835-68-4/Adenosine 5'-(hexahydrogen pentaphosphate), P''''-->5'-ester with 3'-azido-3'-deoxythymidine
- 5828-66-0/ethyl (2Z)-2-[(2-methoxynaphthalen-1-yl)methylidene]-7-methyl-3-oxo-5-thiophen-2-yl-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate
- 1164554-53-3/1-(4-chlorophenyl)-N-(3,4,4-trimethyl-2-sulfanylidene-1,3-thiazolidin-5-yl)methanimine oxide
- 341501-36-8/ethyl 2-({2-[(5-allyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]butanoyl}amino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
- 354539-87-0/2-(4-Methyl-phthalazin-1-ylsulfanyl)-N-o-tolyl-acetamide
- 350680-08-9/4-[2-(4-Methyl-phthalazin-1-ylsulfanyl)-acetylamino]-benzoic acid methyl ester
- 309923-66-8/4-Benzoyl-1-[2-(dimethylamino)ethyl]-5-(3-fluorophenyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one
- 442667-36-9/1-(2-aminoethyl)-4-benzoyl-5-(3,4-dimethoxyphenyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one